Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iqvia Holdings Inc (NY: IQV )

228.53 -1.56 (-0.68%)
Streaming Delayed Price Updated: 3:36 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Iqvia Holdings Inc

< Previous 1 2 3 4 Next >
IQVIA Reports Second-Quarter 2023 Results
From IQVIA Holdings Inc.
Via Business Wire
IQVIA to Announce Second-Quarter 2023 Results on August 1, 2023
From IQVIA Holdings Inc.
Via Business Wire
IQVIA and the NBA Selected for Abbott’s UNIVANTS of Healthcare Excellence Award
From IQVIA
Via Business Wire
IQVIA selected ‘Leader’ in Everest Group Life Sciences Sales and Marketing Operations PEAK Matrix® Assessment 2023
From IQVIA
Via Business Wire
IQVIA Wins Prestigious “Best AI-based Solution for Healthcare” Award in 2023 Artificial Intelligence Breakthrough Awards
From IQVIA
Via Business Wire
IQVIA Launches RIM Smart Labeling to Deliver Intelligence-Driven Approach for Global Label Management
From IQVIA
Via Business Wire
IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
From IQVIA
Via Business Wire
Global Oncology R&D Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes and Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Announces Offering of Senior Secured Notes and Senior Notes
From IQVIA
Via Business Wire
IQVIA Celebrates Sheetal Telang, Winner of Healthcare Businesswoman's Association Rising Star Award
From IQVIA
Via Business Wire
Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute
From IQVIA
Via Business Wire
IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Named a Leader in Everest Group Life Sciences Customer Experience Platforms PEAK Matrix® Assessment 2023
From IQVIA
Via Business Wire
IQVIA to Announce First-Quarter 2023 Results on April 27, 2023
From IQVIA Holdings Inc.
Via Business Wire
Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023
From IQVIA
Via Business Wire
IQVIA Publishes its 2022 Environmental, Social and Governance Report
From IQVIA
Via Business Wire
IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Named to FORTUNE’s 2023 List of “World’s Most Admired Companies,” Ranked #1 in Its Category for the Second Consecutive Year
From IQVIA
Via Business Wire
IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China
From IQVIA
Via Business Wire
IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023
From IQVIA
Via Business Wire
Global Market for Medicines to Rise to $1.9 Trillion by 2027, says Report from IQVIA Institute
From IQVIA
Via Business Wire
IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel
From IQVIA
Via Business Wire
IQVIA Reports Third-Quarter 2022 Results
From IQVIA Holdings Inc.
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at Credit Suisse Annual Healthcare Conference on November 8, 2022
From IQVIA Holdings Inc.
Via Business Wire
Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso
From IQVIA
Via Business Wire
IQVIA to Announce Third-Quarter 2022 Results on October 26, 2022
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation
From IQVIA
Via Business Wire
New IQVIA Study Demonstrates Cost and Time Savings of Decentralized Trials
From IQVIA
Via Business Wire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.